{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:58:21Z","timestamp":1789948701516,"version":"4.0.1"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2014,12,1]]},"DOI":"10.1001\/jamainternmed.2014.5756","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T18:30:37Z","timestamp":1415644237000},"page":"1887","source":"Crossref","is-referenced-by-count":42,"title":["The Withdrawal of Drugs for Commercial Reasons"],"prefix":"10.1001","volume":"174","author":[{"given":"Vinay","family":"Prasad","sequence":"first","affiliation":[{"name":"Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/1930727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T22:16:24Z","timestamp":1481926584000},"score":1,"resource":{"primary":{"URL":"http:\/\/archinte.jamanetwork.com\/article.aspx?doi=10.1001\/jamainternmed.2014.5756"}},"subtitle":["The Incomplete Story of Tositumomab"],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2014.5756","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}